| Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? JN Aucott, AW Rebman, LA Crowder, KB Kortte Quality of Life Research 22, 75-84, 2013 | 190 | 2013 |
| Development of a Case Definition for Post-Treatment Lyme Disease Syndrome JN Aucott, LA Crowder, KB Kortte International Journal of Infectious Disease, 2013 | 108 | 2013 |
| CCL19 as a chemokine risk factor for posttreatment Lyme disease syndrome: a prospective clinical cohort study JN Aucott, MJ Soloski, AW Rebman, LA Crowder, LJ Lahey, CA Wagner, ... Clinical and Vaccine Immunology 23 (9), 757-766, 2016 | 88 | 2016 |
| Serum inflammatory mediators as markers of human Lyme disease activity MJ Soloski, LA Crowder, LJ Lahey, CA Wagner, WH Robinson, JN Aucott PLoS One 9 (4), e93243, 2014 | 77 | 2014 |
| Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early … AW Rebman, LA Crowder, A Kirkpatrick, JN Aucott Clinical rheumatology 34, 585-589, 2015 | 67 | 2015 |
| Screening blood donors for HIV, HCV, and HBV at the American Red Cross: 10-year trends in prevalence, incidence, and residual risk, 2007 to 2016 RY Dodd, LA Crowder, JM Haynes, EP Notari, SL Stramer, WR Steele Transfusion Medicine Reviews 34 (2), 81-93, 2020 | 63 | 2020 |
| Transfusion‐transmitted and community‐acquired babesiosis in New York, 2004 to 2015 JV Linden, MA Prusinski, LA Crowder, L Tonnetti, SL Stramer, DA Kessler, ... Transfusion 58 (3), 660-668, 2018 | 47 | 2018 |
| Creutzfeldt‐Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk LA Crowder, LB Schonberger, RY Dodd, WR Steele Transfusion 57 (8), 1875-1878, 2017 | 40 | 2017 |
| Standardized symptom measurement of individuals with early Lyme disease over time KT Bechtold, AW Rebman, LA Crowder, D Johnson-Greene, JN Aucott Archives of Clinical Neuropsychology 32 (2), 129-141, 2017 | 37 | 2017 |
| Bull’s-eye and nontarget skin lesions of Lyme disease: an internet survey of identification of erythema Migrans JN Aucott, LA Crowder, V Yedlin, KB Kortte Dermatology Research and Practice 2012, 2012 | 24 | 2012 |
| Imaging utilization for the diagnosis of appendicitis in stand-alone children’s hospitals in the United States: trends and costs HJ Otero, L Crowder Journal of the American College of Radiology 14 (5), 603-608, 2017 | 23 | 2017 |
| Lyme disease and post-treatment Lyme disease syndrome: the neglected disease in our own backyard LA Crowder, VA Yedlin, ER Weinstein, KB Kortte, JN Aucott Public Health 128 (9), 784-791, 2014 | 22 | 2014 |
| Prevalence, incidence, and risk Factors of HIV infection in blood donors in the Southeastern United States LA Crowder, WR Steele, EP Notari IV, CK Hopkins, JLO Lima, GA Foster, ... Transfusion, 2016 | 15* | 2016 |
| COVID‐19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors B Lasky, E Goodhue Meyer, WR Steele, LA Crowder, PP Young Transfusion 61 (5), 1471-1478, 2021 | 14 | 2021 |
| Teenage blood donation: demographic trends, adverse reactions and iron balance AF Eder, LA Crowder, WR Steele ISBT Science Series 12 (4), 395-400, 2017 | 13 | 2017 |
| Infectious disease screening LA Crowder, WR Steele, SL Stramer Technical manual, 173-227, 2020 | 9 | 2020 |
| International survey of strategies to mitigate transfusion‐transmitted Trypanosoma cruzi in non‐endemic countries, 2016–2018 LA Crowder, S Wendel, EM Bloch, SF O'Brien, G Delage, S Sauleda, ... Vox Sanguinis 117 (1), 58-63, 2022 | 8 | 2022 |
| Frequency of rare, serious donor reactions: International perspective P Young, L Crowder, W Steele, D Irving, J Pink, JM Kutner, ... Transfusion 61 (6), 1780-1788, 2021 | 8 | 2021 |
| The Press LA Crowder, JM Haynes, EP Notari, SL Stramer, WR Steele JS Dodd, 1883 | 7 | 1883 |
| Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United States JM Haynes, RY Dodd, LA Crowder, EP Notari, SL Stramer Emerging Infectious Diseases 29 (7), 1323, 2023 | 6 | 2023 |
Whitney SteeleHealth Scientist, US Food and Drug AdministrationVerified email at fda.hhs.gov
